+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Cardiac Safety Services Market by Type (Standalone, Integrated), Services (ECG/Holter measurement, Blood Pressure, Cardiac Imaging, Thorough QT Study, Other Services), End User (Pharmaceutical & Biopharmaceutical Companies, CRO) - Global Forecast to 2024

  • ID: 4863373
  • Report
  • November 2019
  • Region: Global
  • 136 Pages
  • Markets and Markets
1 of 6
The Cardiac Safety Services Market is Projected to Reach USD 752 Million by 2024 from USD 442 Million in 2019, at a CAGR of 11.2%.

FEATURED COMPANIES

  • Banook Group
  • Biotrial
  • Certara, L.P.
  • IQVIA
  • Medpace
  • PhysioStim
  • MORE

Growth in this industry is driven by the growing R&D expenditure in the pharmaceutical & biopharmaceutical industry, increased outsourcing of R&D activities, and the increasing number of clinical trials. On the other hand, the high cost of cardiac safety evaluation is the burning issue in this market. In addition, the introduction of new technologies & methods and growth in the biosimilars and biologics market are offering growth opportunities for players in the market.

The ECG/Holter measurement services segment is anticipated to grow at the fastest growth rate during the forecast period.

The cardiac safety services market based on the type of service is categorized into ECG/Holter measurement, blood pressure measurement, cardiovascular imaging, thorough QT studies, and other services. The ECG/Holter measurement segment is expected to register the highest CAGR during the forecast period. The low cost of ECG/Holter measurement services and their wide usage in measuring cardiac activity are the key factors driving the growth of this market.

The integrated services segment is estimated to dominate the market during the analysis period.

By type, the cardiac safety services market is categorized into integrated and standalone services. The integrated services segment accounted for the largest share of the cardiac safety services market. The large share of this segment can be attributed to the benefits of bundled services to oversee end-to-end developments, as opposed to the specificity of standalone services. This helps reduce the time to market for manufacturers.

The pharmaceutical & biopharmaceutical companies segment is estimated to grow at a rapid rate during the analysis period.

Based on end-user, the cardiac safety services market is segmented into pharmaceutical & biopharmaceutical companies and CROs. The pharmaceutical & biopharmaceutical companies segment is expected to be the fastest-growing segment of the global cardiac safety services market during the forecast period. Factors such as the stringent regulations for drug safety and increasing R&D activities to develop new drugs are driving the growth of this segment.

North America is estimated to register the highest CAGR during the study period.

Geographically, the cardiac safety services market was dominated by North America, followed by Europe in 2018. North Americ is estimated to grow at the fastest rate due to the presence of major pharmaceutical & biopharmaceutical companies and the large number of clinical trials performed in the region.

Breakdown of Profiles of Primary Participants:

  • By Company Type: Tier 1: 20%, Tier 2: 45%, and Tier 3: 35%
  • By Designation: C-level: 30%, Director-level: 20%, and Others: 50%
  • By Region: North America: 35%, Europe: 24%, Asia Pacific: 25%, and the Rest of the World: 16%

Key players in the cardiac safety services market include Biotrial (France), Banook Group (France & Canada), Bioclinica (US), Certara L.P. (US), Celerion, Inc. (US), ERT, Inc. (US), Laboratory Corporation of America Holdings (US), Medpace Holdings, Inc. (US), Ncardia AG (Belgium), Richmond Pharmacology (UK), PhysioStim (France), Shanghai Medicilon Inc. (China), SGS S.A. (Switzerland), BioTelemetry, Inc. (US), IQVIA (US), and Pharmaceutical Product Development LLC (US).

Research Coverage:

The report analyzes the cardiac safety services market by type of service, type, end-user, and region. Apart from comprehensive geographic services analysis and market sizing, the report also provides a competitive landscape that covers the growth strategies adopted by market players over the last three years. In addition, the company profiles include the services portfolios, developments, and strategies adopted by prominent market players to maintain and increase their shares in the market. Market research data, current market size, and forecast of future trends will help key market players and new entrants to make the necessary decisions regarding service offerings, geographic focus, change in strategic approach, and levels of output to remain successful in the market.

Key Benefits of Buying the Report:

This report will enable both established firms and new entrants/smaller firms to gauge the pulse of the market, which, in turn, will help these firms garner greater market shares. Firms purchasing the report can use any one, or a combination of the below mentioned five strategies for strengthening their market shares.

The report provides insights on the following pointers:

  • Market Penetration: Comprehensive information on the services portfolios of the top players in the cardiac safety services market
  • Services Development/Innovation: Detailed insights on the R&D activities, and services launches, partnerships & agreements in the cardiac safety services market
  • Competitive Assessment: In-depth assessment of the market strategies, geographic and business segments, and services portfolios of the leading players in the cardiac safety services market
  • Market Development: Detailed information about emerging markets. The report analyzes the market for various cardiac safety services across geographies
  • Market Diversification: Exhaustive information about new services, untapped geographies, recent developments, and investments in the cardiac safety services market
Note: Product cover images may vary from those shown
2 of 6

FEATURED COMPANIES

  • Banook Group
  • Biotrial
  • Certara, L.P.
  • IQVIA
  • Medpace
  • PhysioStim
  • MORE

1 Introduction
1.1 Objectives of the Study
1.2 Market Definition
1.3 Market Scope
1.3.1 Markets Covered
1.3.2 Years Considered for the Study
1.4 Currency
1.5 Limitations
1.6 Stakeholders

2 Research Methodology
2.1 Research Data
2.1.1 Secondary Data
2.1.1.1 Key Data From Secondary Sources
2.1.2 Primary Data
2.1.2.1 Key Data From Primary Sources
2.1.2.2 Key Industry Insights
2.2 Market Size Estimation
2.2.1 Market Size Estimation: Bottom-Up Approach
2.2.2 Market Size Estimation: Top-Down Approach
2.2.3 Growth Forecast
2.3 Market Breakdown and Data Triangulation
2.4 Assumptions for the Study

3 Executive Summary

4 Premium Insights
4.1 Cardiac Safety Services Market Overview
4.2 North America: Market, By End User & Country (2018)
4.3 Market: Geographic Growth Opportunities

5 Market Overview
5.1 Introduction
5.2 Market Dynamics
5.2.1 Drivers
5.2.1.1 Growing R&D Expenditure in the Pharmaceutical & Biopharmaceutical Industry
5.2.1.2 Increased Outsourcing of R&D Activities
5.2.1.3 Increasing Number of Clinical Trials
5.2.2 Opportunities
5.2.2.1 Introduction of New Technologies and Methods
5.2.2.2 Growth in the Biosimilars and Biologics Markets
5.2.3 Challenges
5.2.3.1 High Cost of Cardiac Safety Evaluation

6 Cardiac Safety Services Market, By Type of Service
6.1 Introduction
6.2 ECG/Holter Measurement Services
6.2.1 ECG/Holter Measurement Services Help in the R&D of Novel Methods for Clinical Trials and Drug Discovery
6.3 Blood Pressure Measurement Services
6.3.1 Increasing R&D Activities to Drive the Growth of the Blood Pressure Measurement Services Segment
6.4 Cardiovascular Imaging Services
6.4.1 Cardiovascular Imaging Services Help in Drug Evaluation
6.5 Thorough QT Studies
6.5.1 Need to Meet Stringent Regulatory Requirements is Driving the Demand for Thorough QT Studies
6.6 Other Services

7 Cardiac Safety Services Market, By Type
7.1 Introduction
7.2 Integrated Services
7.2.1 Integrated Services Dominate the Market
7.3 Standalone Services
7.3.1 Standalone Services Segment Witnessing Growth Due to Cost-Effectiveness

8 Cardiac Safety Services Market, By End User
8.1 Introduction
8.2 Pharmaceutical & Biopharmaceutical Companies
8.2.1 Increasing R&D By Pharmaceutical & Biopharmaceutical Companies to Drive the Demand for Cardiac Safety Services
8.3 Contract Research Organizations
8.3.1 Increasing Outsourcing of Drug Discovery Processes to Support the Growth of This End-User Segment

9 Cardiac Safety Services Market, By Region
9.1 Introduction
9.2 North America
9.2.1 US
9.2.1.1 US Dominates the Global Market for Cardiac Safety Services
9.2.2 Canada
9.2.2.1 Canada has High-Quality Clinical Trial Infrastructure and Expertise
9.3 Europe
9.3.1 Germany
9.3.1.1 Availability of Skilled Staff and Flexible Labor Laws Have Made Germany A Popular Hub in the Eu for Clinical Trials
9.3.2 UK
9.3.2.1 Steady Growth of Pharmaceutical R&D Expenditure Indicates Favorable Prospects for Cardiac Safety Services
9.3.3 France
9.3.3.1 A Large Number of Cancer Therapy-Focused Clinical Trials are Conducted in France
9.3.4 Italy
9.3.4.1 Italy’s Strong Pharma Industry and Availability of Funding for Drug Development Have Fueled Market Growth
9.3.5 Spain
9.3.5.1 Growing Investment in Pharmaceutical R&D and Favorable Climate for Approvals are Driving Market Growth
9.3.6 Rest of Europe
9.4 Asia Pacific
9.4.1 China
9.4.1.1 China Dominates the APAC Market for Cardiac Safety Services
9.4.2 Japan
9.4.2.1 Strong Ip Rights and Supportive Policies Have Strengthened the R&D Sector in Japan
9.4.3 India
9.4.3.1 Lack of Language Barriers and Availability of Trained Resources Make India an Attractive Destination for Clinical Trials
9.4.4 Australia
9.4.4.1 Favorable R&D Tax Incentives and Cash Rebates Have Driven Clinical Trial Activity in Australia
9.4.5 Rest of Asia Pacific
9.5 Rest of the World

10 Competitive Landscape
10.1 Overview
10.2 Market Player Ranking
10.3 Competitive Situation and Trends
10.3.1 Services Launches & Upgrades
10.3.2 Expansions
10.3.3 Acquisitions
10.3.4 Partnerships, Alliances, and Agreements
10.3.5 Other Strategies
10.4 Competitive Leadership Mapping - Overall Market (2019)
10.4.1 Visionary Leaders
10.4.2 Dynamic Differentiators
10.4.3 Innovators
10.4.4 Emerging Companies

11 Company Profiles
Business Overview, Services Offered, Recent Developments, and Author's View
11.1 Bioclinica (A Subsidiary of Cinven)
11.2 Labcorp
11.3 BioTelemetry, Inc.
11.4 ERT, Inc.
11.5 Banook Group
11.6 IQVIA
11.7 Biotrial
11.8 Certara, L.P.
11.9 Celerion, Inc.
11.10 Medpace
11.11 Ncardia
11.12 Richmond Pharmacology
11.13 PhysioStim
11.14 Shanghai Medicilon Inc.
11.15 Pharmaceutical Product Development LLC
11.16 SGS S.A.

Details on Business Overview, Services Offered, Recent Developments, and Author's View Might Not Be Captured in Case of Unlisted Companies.

12 Appendix
12.1 Discussion Guide
12.2 Knowledge Store: Subscription Portal
12.3 Available Customizations
12.4 Related Reports
12.5 Author Details

List of Tables

Table 1 R&D Expenditure & Percentage Change, By Company
Table 2 Market, By Type of Service, 2017-2024 (USD Million)
Table 3 ECG/Holter Measurement Services Market, By Region, 2017-2024 (USD Million)
Table 4 North America: ECG/Holter Measurement Services Market, By Country, 2017-2024 (USD Million)
Table 5 Europe: ECG/Holter Measurement Services Market, By Country, 2017-2024 (USD Million)
Table 6 Asia Pacific: ECG/Holter Measurement Services Market, By Country, 2017-2024 (USD Million)
Table 7 Blood Pressure Measurement Services Market, By Region, 2017-2024 (USD Million)
Table 8 North America: Blood Pressure Measurement Services Market, By Country, 2017-2024 (USD Million)
Table 9 Europe: Blood Pressure Measurement Services Market, By Country, 2017-2024 (USD Million)
Table 10 Asia Pacific: Blood Pressure Measurement Services Market, By Country, 2017-2024 (USD Million)
Table 11 Cardiovascular Imaging Services Market, By Region, 2017-2024 (USD Million)
Table 12 North America: Cardiovascular Imaging Services Market, By Country, 2017-2024 (USD Million)
Table 13 Europe: Cardiovascular Imaging Services Market, By Country, 2017-2024 (USD Million)
Table 14 Asia Pacific: Cardiovascular Imaging Services Market, By Country, 2017-2024 (USD Million)
Table 15 Thorough QT Studies Market, By Region, 2017-2024 (USD Million)
Table 16 North America: Thorough QT Studies Market, By Country, 2017-2024 (USD Million)
Table 17 Europe: Thorough QT Studies Market, By Country, 2017-2024 (USD Million)
Table 18 Asia Pacific: Thorough QT Studies Market, By Country, 2017-2024 (USD Million)
Table 19 Other Cardiac Safety Services Market, By Region, 2017-2024 (USD Million)
Table 20 North America: Other Market, By Country, 2017-2024 (USD Million)
Table 21 Europe: Other Market, By Country, 2017-2024 (USD Million)
Table 22 Asia Pacific: Other Market, By Country, 2017-2024 (USD Million)
Table 23 Market, By Type, 2017-2024 (USD Million)
Table 24 Integrated Market, By Region, 2017-2024 (USD Million)
Table 25 North America: Integrated Cardiac Safety Services Market, By Country, 2017-2024 (USD Million)
Table 26 Europe: Integrated Market, By Country, 2017-2024 (USD Million)
Table 27 Asia Pacific: Integrated Market, By Country, 2017-2024 (USD Million)
Table 28 Standalone Market, By Region, 2017-2024 (USD Million)
Table 29 North America: Standalone Market, By Country, 2017-2024 (USD Million)
Table 30 Europe: Standalone Market, By Country, 2017-2024 (USD Million)
Table 31 Asia Pacific: Standalone Market, By Country, 2017-2024 (USD Million)
Table 32 Cardiac Safety Services Market, By End User, 2017-2024 (USD Million)
Table 33 Market for Pharmaceutical & Biopharmaceutical Companies, By Region, 2017-2024 (USD Million)
Table 34 North America: Cardiac Safety Services Market for Pharmaceutical & Biopharmaceutical Companies, By Country, 2017-2024 (USD Million)
Table 35 Europe: Market for Pharmaceutical & Biopharmaceutical Companies, By Country, 2017-2024 (USD Million)
Table 36 Asia Pacific: Market for Pharmaceutical & Biopharmaceutical Companies, By Country, 2017-2024 (USD Million)
Table 37 Market for Contract Research Organizations, By Region, 2017-2024 (USD Million)
Table 38 North America: Cardiac Safety Services Market for Contract Research Organizations, By Country, 2017-2024 (USD Million)
Table 39 Europe: Market for Contract Research Organizations, By Country, 2017-2024 (USD Million)
Table 40 Asia Pacific: Market for Contract Research Organizations, By Country, 2017-2024 (USD Million)
Table 41 Market, By Region, 2017-2024 (USD Million)
Table 42 North America: Market, By Country, 2017-2024 (USD Million)
Table 43 North America: Market, By Type of Service, 2017-2024 (USD Million)
Table 44 North America: Cardiac Safety Services Market, By Type, 2017-2024 (USD Million)
Table 45 North America: Market, By End User, 2017-2024 (USD Million)
Table 46 Total Number of Clinical Trials in the US (Till October 2019)
Table 47 Number of Clinical Trials Started in the Us, By Company, 2017
Table 48 US: Market, By Type of Service, 2017-2024 (USD Million)
Table 49 US: Cardiac Safety Services Market, By Type, 2017-2024 (USD Million)
Table 50 US: Market, By End User, 2017-2024 (USD Million)
Table 51 Number of Active Clinical Trials in Canada, By Condition (2019)
Table 52 Number of Active Clinical Trials in Canada, By Company, 2017
Table 53 Canada: Market, By Type of Service, 2017-2024 (USD Million)
Table 54 Canada: Market, By Type, 2017-2024 (USD Million)
Table 55 Canada: Market, By End User, 2017-2024 (USD Million)
Table 56 Europe: Market, By Country, 2017-2024 (USD Million)
Table 57 Europe: Cardiac Safety Services Market, By Type of Service, 2017-2024 (USD Million)
Table 58 Europe: Market, By Type, 2017-2024 (USD Million)
Table 59 Europe: Market, By End User, 2017-2024 (USD Million)
Table 60 Germany: Market, By Type of Service, 2017-2024 (USD Million)
Table 61 Germany: Market, By Type, 2017-2024 (USD Million)
Table 62 Germany: Table 63 UK: Market, By Type of Service, 2017-2024 (USD Million)
Table 64 UK: Market, By Type, 2017-2024 (USD Million)
Table 65 UK: Market, By End User, 2017-2024 (USD Million)
Table 66 Number of Clinical Trials Started in France, By Company, 2017
Table 67 France: Market, By Type of Service, 2017-2024 (USD Million)
Table 68 France: Market, By Type, 2017-2024 (USD Million)
Table 69 France: Market, By End User, 2017-2024 (USD Million)
Table 70 Number of Clinical Trials Started in Italy, By Company, 2017
Table 71 Italy: Market, By Type of Service, 2017-2024 (USD Million)
Table 72 Italy: Market, By Type, 2017-2024 (USD Million)
Table 73 Italy: Market, By End User, 2017-2024 (USD Million)
Table 74 Spain: Market, By Type of Service, 2017-2024 (USD Million)
Table 75 Spain: Market, By Type, 2017-2024 (USD Million)
Table 76 Spain: Market, By End User, 2017-2024 (USD Million)
Table 77 RoE: Market, By Type of Service, 2017-2024 (USD Million)
Table 78 RoE: Market, By Type, 2017-2024 (USD Million)
Table 79 RoE: Market, By End User, 2017-2024 (USD Million)
Table 80 Clinical Trials in the Asia Pacific, By Therapeutic Area, 2017
Table 81 APAC: Market, By Country, 2017-2024 (USD Million)
Table 82 APAC: Market, By Type of Service, 2017-2024 (USD Million)
Table 83 APAC: Cardiac Safety Services Market, By Type, 2017-2024 (USD Million)
Table 84 APAC: Market, By End User, 2017-2024 (USD Million)
Table 85 China: Market, By Type of Service, 2017-2024 (USD Million)
Table 86 China: Market, By Type, 2017-2024 (USD Million)
Table 87 China: Market, By End User, 2017-2024 (USD Million)
Table 88 Japan: Market, By Type of Service, 2017-2024 (USD Million)
Table 89 Japan: Market, By Type, 2017-2024 (USD Million)
Table 90 Japan: Market, By End User, 2017-2024 (USD Million)
Table 91 India: Market, By Type of Service, 2017-2024 (USD Million)
Table 92 India: Cardiac Safety Services Market, By Type, 2017-2024 (USD Million)
Table 93 India: Market, By End User, 2017-2024 (USD Million)
Table 94 Australia: Market, By Type of Service, 2017-2024 (USD Million)
Table 95 Australia: Market, By Type, 2017-2024 (USD Million)
Table 96 Australia: Market, By End User, 2017-2024 (USD Million)
Table 97 RoAPAC: Market, By Type of Service, 2017-2024 (USD Million)
Table 98 RoAPAC: Market, By Type, 2017-2024 (USD Million)
Table 99 RoAPAC: Market, By End User, 2017-2024 (USD Million)
Table 100 RoW: Market, By Type of Service, 2017-2024 (USD Million)
Table 101 RoW: Market, By Type, 2017-2024 (USD Million)
Table 102 RoW: Market, By End User, 2017-2024 (USD Million)
Table 103 Global Cardiac Safety Services Market Player Ranking, 2018
Table 104 Service Launches & Upgrades, 2016-2019
Table 105 Expansions, 2016-2019
Table 106 Acquisitions, 2016-2019
Table 107 Partnerships, Alliances, and Agreements, 2016-2019
Table 108 Other Strategies, 2016- 2019

List of Figures

Figure 1 Cardiac Safety Services Market
Figure 2 Research Design
Figure 3 Breakdown of Primary Interviews: By Company Type, Designation, and Region
Figure 4 Bottom-Up Approach
Figure 5 Top-Down Approach
Figure 6 Data Triangulation Methodology
Figure 7 Market, By Type of Service, 2019 Vs. 2024 (USD Million)
Figure 8 Market, By Type, 2019 Vs. 2024 (USD Million)
Figure 9 Market, By End User, 2019 Vs. 2024 (USD Million)
Figure 10 Market, By Region, 2019 Vs. 2024 (USD Million)
Figure 11 Increasing R&D Expenditure in the Pharmaceutical & Biotechnology Industry to Drive Market Growth
Figure 12 Pharmaceutical & Biopharmaceutical Companies Were the Largest End Users of Cardiac Safety Services in the North American Market in 2018
Figure 13 The US to Register the Highest Growth in the Cardiac Safety Services Market During the Forecast Period
Figure 14 Market: Drivers, Opportunities, and Challenges
Figure 15 Active Pharmaceutical Pipeline, January 2009 to January 2019
Figure 16 Total Number of Registered Studies (2005-2017)
Figure 17 Trial Count By Phase & Therapeutic Area, 2017
Figure 18 R&D Spending of Pharma Member Companies (USD Billion)
Figure 19 Total Number of Clinical Trials: Global Vs. North America (October 2019)
Figure 20 North America: Market Snapshot
Figure 21 UK: Pharmaceutical R&D Expenditure, 2013-2017
Figure 22 Spain: Pharmaceutical R&D Expenditure, 2011-2017
Figure 23 Clinical Trial Penetration: Developed Vs. Developing Countries, 2016
Figure 24 Asia Pacific: Market Snapshot
Figure 25 Service Launch and Upgradation - Key Growth Strategies Adopted By Market Players From 2016 to 2019
Figure 26 Competitive Leadership Mapping of the Cardiac Safety Services Market
Figure 27 Labcorp: Company Snapshot
Figure 28 BioTelemetry: Company Snapshot
Figure 29 IQVIA: Company Snapshot
Figure 30 MeDPAce: Company Snapshot
Figure 31 Ncardia: Company Snapshot
Figure 32 SGS S.A.: Company Snapshot

Note: Product cover images may vary from those shown
3 of 6

Loading
LOADING...

4 of 6
5 of 6
  • Banook Group
  • Bioclinica (A Subsidiary of Cinven)
  • BioTelemetry, Inc.
  • Biotrial
  • Celerion, Inc.
  • Certara, L.P.
  • ERT, Inc.
  • IQVIA
  • Labcorp
  • Medpace
  • Ncardia
  • Pharmaceutical Product Development LLC
  • PhysioStim
  • Richmond Pharmacology
  • SGS S.A.
  • Shanghai Medicilon Inc.
Note: Product cover images may vary from those shown
6 of 6

Loading
LOADING...

Adroll
adroll